Respond to My FDA Action
What You Are Dealing With
You received a 483 or Warning Letter and the response deadline is already running. Your team is stretched managing day-to-day operations and now this lands on top of everything else. The pressure is real: the FDA expects a response that demonstrates you fully understand the findings, have identified the true root causes, and have a remediation plan that is credible and achievable. Getting this wrong or missing the timeline makes the situation significantly worse. You need experienced help now, not after you have spent two weeks trying to figure out where to start.
How We Approach It
We assess the full scope of the findings, identify root causes that go beyond what the FDA cited, and develop a response that meets agency expectations. We then manage the remediation through to closure so your team is not carrying this alone while trying to keep everything else running.
What We Have Done
A pharmaceutical client received a Warning Letter with findings spanning their entire quality system, affecting manufacturing, packaging, laboratory, procurement, and IT. MEDVACON deployed a remediation team, rebuilt the quality system to current FDA standards, and successfully had the Warning Letter lifted.
A contract packaging company received an FDA Form 483 related to cleaning validation. MEDVACON led the response, developed an enhanced cleaning validation program that met FDA requirements, and managed the selection of a qualified testing laboratory. The client submitted the response and expressed strong satisfaction with the outcome.